156 related articles for article (PubMed ID: 24256349)
21. Consumer knowledge about over-the-counter NSAIDs: they don't know what they don't know.
Mullan J; Weston KM; Bonney A; Burns P; Mullan J; Rudd R
Aust N Z J Public Health; 2017 Apr; 41(2):210-214. PubMed ID: 27774735
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of gastric tolerability, antinociceptive and antiinflammatory activity of combination NSAIDs in rats.
Kalra BS; ; Chaturvedi S; Tayal V; Gupta U
Indian J Dent Res; 2009; 20(4):418-22. PubMed ID: 20139563
[TBL] [Abstract][Full Text] [Related]
23. Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerability.
Brune K
Curr Med Res Opin; 2007 Dec; 23(12):2985-95. PubMed ID: 17949535
[TBL] [Abstract][Full Text] [Related]
24. Ibuprofen: a journey from prescription to over-the-counter use.
Moore N
J R Soc Med; 2007; 100 Suppl 48():2-6. PubMed ID: 18335846
[TBL] [Abstract][Full Text] [Related]
25. Actual use of and adherence to ibuprofen 400 mg tablet dosing instructions in a simulated OTC environment
.
Meeves S; Leyva R; Richardson C; Wilson B; Savastano DM
Int J Clin Pharmacol Ther; 2017 Jul; 55(7):547-557. PubMed ID: 28513425
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease.
Hennekens CH; Borzak S
J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):41-50. PubMed ID: 18287589
[TBL] [Abstract][Full Text] [Related]
27. Gastrointestinal safety of NSAIDs and over-the-counter analgesics.
Bjarnason I
Int J Clin Pract Suppl; 2013 Jan; (178):37-42. PubMed ID: 23163547
[TBL] [Abstract][Full Text] [Related]
28. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study.
Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studies.
Salvo F; Antoniazzi S; Duong M; Molimard M; Bazin F; Fourrier-Réglat A; Pariente A; Moore N
Expert Opin Drug Saf; 2014 May; 13(5):573-85. PubMed ID: 24697248
[TBL] [Abstract][Full Text] [Related]
30. [Application of a seven-day buprenorphine transdermal patch in multimorbid patients on long-term ibuprofen or diclofenac].
Böhme K; Heckes B; Thomitzek K
MMW Fortschr Med; 2011 Jan; 152 Suppl 4():125-32. PubMed ID: 21598463
[TBL] [Abstract][Full Text] [Related]
31. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
White WB; West CR; Borer JS; Gorelick PB; Lavange L; Pan SX; Weiner E; Verburg KM
Am J Cardiol; 2007 Jan; 99(1):91-8. PubMed ID: 17196469
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.
Schneeweiss S; Solomon DH; Wang PS; Rassen J; Brookhart MA
Arthritis Rheum; 2006 Nov; 54(11):3390-8. PubMed ID: 17075817
[TBL] [Abstract][Full Text] [Related]
33. Dose-dependency of the cardiovascular risks of non-steroidal anti-inflammatory drugs.
Ahmed SA; Al-Lawati H; Jamali F
Inflammopharmacology; 2019 Oct; 27(5):903-910. PubMed ID: 31359235
[TBL] [Abstract][Full Text] [Related]
34. Low-dose diclofenac potassium in the treatment of episodic tension-type headache.
Kubitzek F; Ziegler G; Gold MS; Liu JM; Ionescu E
Eur J Pain; 2003; 7(2):155-62. PubMed ID: 12600797
[TBL] [Abstract][Full Text] [Related]
35. [Cardiovascular side effects of non-steroidal anti-inflammatory drugs in the light of recent recommendations. Diclofenac is not more dangerous].
Horváth VJ; Tabák GÁ; Szabó G; Putz Z; Koós CG; Lakatos P
Orv Hetil; 2015 Mar; 156(13):516-20. PubMed ID: 25796279
[TBL] [Abstract][Full Text] [Related]
36. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C
Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336
[TBL] [Abstract][Full Text] [Related]
37. Safety and usage pattern of low-dose diclofenac when used as an over-the-counter medication: results of an observational cohort study in a community-based pharmacy setting.
Hasford J; Moore N; Hoye K
Int J Clin Pharmacol Ther; 2004 Aug; 42(8):415-22. PubMed ID: 15366321
[TBL] [Abstract][Full Text] [Related]
38. Nonsteroidal anti-inflammatory drug usage and gastrointestinal outcomes in the Republic of Serbia.
Petric M; Tasic L; Sukljevic S
J Pain Palliat Care Pharmacother; 2009; 23(1):40-7. PubMed ID: 19296354
[TBL] [Abstract][Full Text] [Related]
39. Ibuprofen and gastrointestinal safety: a dose-duration-dependent phenomenon.
Bjarnason I
J R Soc Med; 2007; 100 Suppl 48():11-4. PubMed ID: 18335848
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of ibuprofen in man: a single-dose comparison of two over-the-counter, 200 mg preparations.
Karttunen P; Saano V; Paronen P; Peura P; Vidgren M
Int J Clin Pharmacol Ther Toxicol; 1990 Jun; 28(6):251-5. PubMed ID: 2376426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
